Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
California Nanotechnologies (FRA:R14) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
California Nanotechnologies's EV-to-EBIT for today is
California Nanotechnologies's current Enterprise Value is €8.34 Mil.
California Nanotechnologies's EBIT for the trailing twelve months (TTM) ended in Nov. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.65 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
California Nanotechnologies's EV-to-EBITDA for today is:
California Nanotechnologies's current Enterprise Value is €8.34 Mil.
California Nanotechnologies's EBITDA for the trailing twelve months (TTM) ended in Nov. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.01 Mil.
California Nanotechnologies's current Enterprise Value is €8.34 Mil.
California Nanotechnologies's Revenue for the trailing twelve months (TTM) ended in Nov. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.75 Mil.
California Nanotechnologies's current Enterprise Value is €8.34 Mil.
California Nanotechnologies's Cash Flow from Operations for the trailing twelve months (TTM) ended in Nov. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.03 Mil.
California Nanotechnologies's current Enterprise Value is €8.34 Mil.
California Nanotechnologies's Free Cash Flow for the trailing twelve months (TTM) ended in Nov. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.08 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
California Nanotechnologies Enterprise Value Related Terms
California Nanotechnologies Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
California Nanotechnologies Enterprise Value Chart
FRA:R14 vs LIN, SHW, ECL: Enterprise Value Comparison
For the Specialty Chemicals subindustry, California Nanotechnologies's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
California Nanotechnologies Enterprise Value vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, California Nanotechnologies's Enterprise Value distribution charts can be found below:
* The bar in red indicates where California Nanotechnologies's Enterprise Value falls into.
California Nanotechnologies Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
California Nanotechnologies (FRA:R14) has a Enterprise Value of €8.34 Mil as of Jun. 28, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on California Nanotechnologies and its competitors.
Is California Nanotechnologies' Enterprise Value too high?
California Nanotechnologies' current Enterprise Value is €8.34 Mil. Overall, California Nanotechnologies has a GF Score™ of 40/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does California Nanotechnologies' Enterprise Value compare to LIN and SHW?
California Nanotechnologies' Enterprise Value of €8.34 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Chemicals company?
A good Enterprise Value depends on the Chemicals industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on California Nanotechnologies and its competitors. California Nanotechnologies's current Enterprise Value is €8.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is California Nanotechnologies stock overvalued right now?
Based on GuruFocus' analysis, California Nanotechnologies (FRA:R14) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.18, compared to a current price of €0.14 — trading 22.2% below its estimated fair value. The current Enterprise Value is €8.34 Mil. California Nanotechnologies' overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For California Nanotechnologies (FRA:R14), the current Enterprise Value is €8.34 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is California Nanotechnologies (FRA:R14) Overvalued in 2026?
Based on GuruFocus' analysis, California Nanotechnologies stock appears to be undervalued.
The current stock price of €0.14 is trading 22.2% below its estimated GF Value™ of €0.18.
GuruFocus considers California Nanotechnologies to be Modestly Undervalued.
Key valuation signals for FRA:R14:
Enterprise Value: €8.34 Mil
GF Value™: €0.18 vs. price of €0.14 (22.2% below fair value)
No single metric tells the full story. See the FRA:R14 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
California Nanotechnologies Corp engages in the production, and research and development of nanostructured components and materials. Its products include High-Strength Graphite Spark tooling, Plasma Sintering Tooling, Tungsten Carbide Tooling, Carbon Graphite Foil, Carbon Felt and Yarn, and others.
40GF Score
Get the complete analysis for FRA:R14
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:R14 has been successfully added to your 
